SSFF-02

N/A

Report date: 2025/01/26 19:04:16
NME

Base Information

Drug NameSSFF-02
Drug Alias NameSSFF-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 3 antagonistsC-C chemokine receptor type 1 antagonistsC-C chemokine receptor type 5 antagonists +[4] 
TargetsC-C chemokine receptor type 7C-C chemokine receptor type 5C-C chemokine receptor type 3 +[4] 
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas At El Paso Acc Soc
China Registration ClassN/A

Develop Information

Active CompaniesMicar Innovation LtdUniversity Of Texas At El Paso Acc Soc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A